What exactly is Symprove?

Proven by independent experts

Recommended by clinical and scientific experts

"In order to be effective, probiotics need to 'arrive, survive and thrive’"

Dr Sarah Jarvis MBE

Medical broadcaster, practicing GP and clinical consultant for patient.info

Symprove is different from other probiotics because it is water-based, which means it limits exposure to gastric juices and digestives enzymes

Professor Simon Gaisford

Head of Pharmaceutics, UCL School of Pharmacy

Bladder & Bowel UK are proud to partner with Symprove to raise awareness of a product that has already been helpful to so many people

Karen Irwin

Bladder & Bowel UK

In a world where there are many claims about gut health (with good evidence!), I'm so enthused by Symprove's research, and what we are seeing from the results.

Laura Tilt

Registered Dietitian

92% of people report a difference with Symprove over 3 months and we offer healthcare professionals a free trial to see for themselves

Sammie Gill

Gastroenterology Dietitian, Symprove

Symprove bacteria

Symprove contains four live strains of bacteria:*

Lactobacillus acidophilus

NCIMB 30175

Lactiplantibacillus plantarum

NCIMB 30173

Lacticaseibacillus rhamnosus 

NCIMB 30174

Enterococcus faecium

NCIMB 30176

Lactiplantibacillus species

Enterococcus faecium

Symprove safety

  • >30,000 people take Symprove every month6
  • Randomised controlled trials investigating Symprove in those with pre-existing medical conditions, have been approved by ethics committees and no serious adverse events have been recorded in any trial7-9
  • No serious adverse events have been recorded since commercial sales began in 20106

1. Fredua-Agyeman M, et al. Benef Microbes 2015;6(1):141–51.

2.  Moens F, et al. Int J Pharm 2019;555:1-10.

3.  Goldstein E, et al. Clin Infect Dis 2015;60(2):S98-S107.

4.  European Food Safety Authority (EFSA). Updated list of QPS-recommended microorganisms for safety risk assessments carried out by EFSA.DOI 10.5281/zenodo.1146566.

5. Gelsomino R, et al. Appl Environ Microbiol 2002;68(7):3560-5.

6. Symprove data on file 2023.

7. Sisson G, et al. Aliment Pharmacol Ther 2014;40(1):51–62.

8. Kvasnovsky CL, et al. Inflammopharmcology 2017; doi: 10.1007/s10787-017-0363-y.

9. Bjarnason I, et al. Inflammopharmacology 2019;27(3):465–73.

*Symprove contains four live strains of bacteria: Lacticaseibacillus rhamnosus NCIMB 30174, Enterococcus faecium NCIMB 30176, Lactobacillus acidophilus NCIMB 30175, Lactiplantibacillus plantarum NCIMB 30173. The bacteria in Symprove have all been independently characterised by the NCIMB (The National Collection of Industrial and Marine Bacteria) using the latest DNA sequencing and mass spectrometry techniques. These methods have enabled characterisation of the genera, species and strains.

Symprove delivers 10 billion CFUs (colony-forming units) per 70ml cup, consistent with amount used in human clinical research trials.

Latest from our team of experts